Cargando…
CYP1A1 MspI polymorphism and acute myeloid leukemia risk: meta-analyses based on 5018 subjects
BACKGROUND: Evidence indicates that CYP1A1 MspI polymorphism might be a possible risk factor for several malignancies. A growing body of literature has been devoted to the association of CYP1A1 MspI polymorphism with acute myeloid leukemia (AML). However, the results remain conflicting. The aim of t...
Autores principales: | Zhuo, Wenlei, Zhang, Liang, Wang, Yan, Zhu, Bo, Chen, Zhengtang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3444413/ https://www.ncbi.nlm.nih.gov/pubmed/22846179 http://dx.doi.org/10.1186/1756-9966-31-62 |
Ejemplares similares
-
MspI and Ile462Val Polymorphisms in CYP1A1 and Overall Cancer Risk: A Meta-Analysis
por: Wu, Bin, et al.
Publicado: (2013) -
Association of CYP1A1 MspI polymorphism in the esophageal cancer risk: a meta-analysis in the Chinese population
por: Zheng, Hui, et al.
Publicado: (2015) -
Association between the CYP1A1 MspI polymorphism and risk of head and neck cancer: a meta-analysis
por: Mohammadi, Hady, et al.
Publicado: (2022) -
CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: An updated meta-analysis and review
por: Zhan, Ping, et al.
Publicado: (2011) -
Relationship between MspI polymorphism of CYP1A1 gene and the risk of endometriosis in an Iranian population: A case-control study
por: Babaki, Azam, et al.
Publicado: (2018)